Literature DB >> 7518396

Activation of human peripheral monocytes by angiotensin II.

A W Hahn1, U Jonas, F R Bühler, T J Resink.   

Abstract

This study has investigated the ability of the vasoconstrictor peptide angiotensin II to activate human peripheral blood monocytes. Activation was monitored by measuring both the release of tumor necrosis factor alpha from monocytes and their adhesion to monolayers of human endothelial cells. Angiotensin II-elicited activation of monocytes was dose-dependent (half-maximally effective concentration approximately 0.2 nM), saturable (maximally effective concentration approximately 5 nM), and sensitive to inhibition by the angiotensin type 1 receptor antagonist ZD 7155. Such direct actions imply that angiotensin II is an important candidate stimulus for the subendothelial infiltration of monocytes observed in atherogenesis and hypertension.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518396     DOI: 10.1016/0014-5793(94)00531-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  41 in total

1.  Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor.

Authors:  G Wolf; F N Ziyadeh; F Thaiss; J Tomaszewski; R J Caron; U Wenzel; G Zahner; U Helmchen; R A Stahl
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Angiotensin II Type-2 receptors modulate inflammation through signal transducer and activator of transcription proteins 3 phosphorylation and TNFα production.

Authors:  Peter M Abadir; Jeremy D Walston; Robert M Carey; Helmy M Siragy
Journal:  J Interferon Cytokine Res       Date:  2011-02-02       Impact factor: 2.607

3.  The frail renin-angiotensin system.

Authors:  Peter M Abadir
Journal:  Clin Geriatr Med       Date:  2011-02       Impact factor: 3.076

Review 4.  Interactions Between the Immune and the Renin-Angiotensin Systems in Hypertension.

Authors:  Nathan P Rudemiller; Steven D Crowley
Journal:  Hypertension       Date:  2016-06-27       Impact factor: 10.190

5.  Augmenting Renal Lymphatic Density Prevents Angiotensin II-Induced Hypertension in Male and Female Mice.

Authors:  Dakshnapriya Balasubbramanian; Catalina A Lopez Gelston; Alexandra H Lopez; Geina Iskander; Winter Tate; Haley Holderness; Joseph M Rutkowski; Brett M Mitchell
Journal:  Am J Hypertens       Date:  2020-01-01       Impact factor: 2.689

Review 6.  Skeletal muscle inflammation and insulin resistance in obesity.

Authors:  Huaizhu Wu; Christie M Ballantyne
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

7.  Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer.

Authors:  Hiroji Uemura; Hisashi Hasumi; Takashi Kawahara; Shinpei Sugiura; Yasuhide Miyoshi; Noboru Nakaigawa; Jun-ichi Teranishi; Kazumi Noguchi; Hitoshi Ishiguro; Yoshinobu Kubota
Journal:  Int J Clin Oncol       Date:  2005-12       Impact factor: 3.402

8.  Leukocyte-dependent responses of the microvasculature to chronic angiotensin II exposure.

Authors:  Alper Yildirim; Janice Russell; Li-Sue S Yan; Elena Y Senchenkova; D Neil Granger
Journal:  Hypertension       Date:  2012-10-22       Impact factor: 10.190

9.  Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo.

Authors:  Rossana Estellés; Javier López-Martín; Lara Milian; José-Enrique O'Connor; Magdalena Martínez-Losa; Miguel Cerdá-Nicolás; Edet M Anam; María Dolores Ivorra; Andrew C Issekutz; Julio Cortijo; Esteban J Morcillo; Maria Amparo Blázquez; Maria-Jesús Sanz
Journal:  Br J Pharmacol       Date:  2003-10-14       Impact factor: 8.739

10.  Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein(E)-deficient mice.

Authors:  F Jiang; G T Jones; G J Dusting
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.